Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.01 USD | -0.23% | -2.07% | -14.23% |
May. 16 | Everlasting momentum | |
May. 16 | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 47.84 | 49.14 | 54.23 |
Spread/Res. | -8.01% | -10.44% | -18.85% |
Spread/Supp. | +0.78% | +0.78% | +0.05% |
Support | 43.67 | 43.67 | 43.99 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- BMY Stock
- Charts Bristol-Myers Squibb Company